Balcom Alexandra, CFO of Nuvalent, Inc. (NUVL), sold shares on the open market 35 times over the last year, totaling about $14.6 million. Her most recent sale occurred on January 6, 2026. These transactions rank her 862nd among 11,678 insiders in our database by sale value, well above the average of $8.6 million across 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 11430 | $0.00 | 138,796.0000 | 72,143,466 | 7.61% | 0.02% |
| April 1, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 2469 | $106.18 | 85,533.0000 | 72,143,466 | 2.81% | 0.00% |
| April 1, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 5417 | $105.30 | 88,002.0000 | 72,143,466 | 5.80% | 0.01% |
| April 1, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 3544 | $104.39 | 93,419.0000 | 72,143,466 | 3.66% | 0.00% |
| April 1, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 11430 | $1.08 | 96,963.0000 | 72,143,466 | 13.36% | 0.02% |
| March 24, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 11430 | $1.08 | 110,663.0000 | 72,143,466 | 11.52% | 0.02% |
| March 24, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 2599 | $95.03 | 108,064.0000 | 72,143,466 | 2.35% | 0.00% |
| March 24, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 11430 | $0.00 | 150,226.0000 | 72,143,466 | 7.07% | 0.02% |
| March 25, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 13700 | $100.16 | 85,533.0000 | 72,143,466 | 13.81% | 0.02% |
| March 24, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1160 | $96.50 | 99,233.0000 | 72,143,466 | 1.16% | 0.00% |
| March 24, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 7671 | $95.88 | 100,393.0000 | 72,143,466 | 7.10% | 0.01% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1119 | $96.85 | 87,160.0000 | 72,143,466 | 1.27% | 0.00% |
| Jan. 7, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 72,143,466 | 9999.99% | 0.02% |
| Jan. 7, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | A | Class A Common Stock | 17500 | $0.00 | 99,233.0000 | 72,143,466 | 21.41% | 0.02% |
| Jan. 6, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 225 | $98.40 | 81,733.0000 | 72,143,466 | 0.27% | 0.00% |
| Jan. 6, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1635 | $97.33 | 81,958.0000 | 72,143,466 | 1.96% | 0.00% |
| Jan. 6, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1321 | $96.75 | 83,593.0000 | 72,143,466 | 1.56% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 317 | $98.52 | 84,914.0000 | 72,143,466 | 0.37% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1929 | $97.96 | 85,231.0000 | 72,143,466 | 2.21% | 0.00% |
| Jan. 5, 2026 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 871 | $96.06 | 88,279.0000 | 72,143,466 | 0.98% | 0.00% |
| Dec. 22, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 34500 | $0.00 | 161,656.0000 | 72,143,466 | 17.59% | 0.05% |
| Dec. 22, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 34500 | $1.08 | 89,150.0000 | 72,143,466 | 63.13% | 0.05% |
| Dec. 8, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 100 | $111.32 | 54,650.0000 | 72,143,466 | 0.18% | 0.00% |
| Dec. 8, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 6984 | $110.31 | 54,750.0000 | 72,143,466 | 11.31% | 0.01% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 13125 | $72.35 | 81,734.0000 | 72,143,466 | 19.13% | 0.02% |
| Nov. 18, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 729 | $0.00 | 33,646.0000 | 72,143,466 | 2.12% | 0.00% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 13125 | $0.00 | 34,375.0000 | 72,143,466 | 27.63% | 0.02% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 6875 | $0.00 | 29,101.0000 | 72,143,466 | 19.11% | 0.01% |
| Nov. 18, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 509 | $104.54 | 61,734.0000 | 72,143,466 | 0.82% | 0.00% |
| Nov. 18, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 220 | $103.61 | 62,243.0000 | 72,143,466 | 0.35% | 0.00% |
| Nov. 18, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 729 | $72.35 | 62,463.0000 | 72,143,466 | 1.18% | 0.00% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 380 | $103.68 | 61,734.0000 | 72,143,466 | 0.61% | 0.00% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 5055 | $103.27 | 62,114.0000 | 72,143,466 | 7.53% | 0.01% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 3194 | $102.13 | 67,169.0000 | 72,143,466 | 4.54% | 0.00% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 4496 | $100.58 | 70,363.0000 | 72,143,466 | 6.01% | 0.01% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 3266 | $95.12 | 74,859.0000 | 72,143,466 | 4.18% | 0.00% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 3609 | $93.80 | 78,125.0000 | 72,143,466 | 4.42% | 0.01% |
| Nov. 17, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 6875 | $6.89 | 68,609.0000 | 72,143,466 | 11.14% | 0.01% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 1683 | $0.00 | 28,979.0000 | 72,143,466 | 5.49% | 0.00% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1683 | $85.57 | 61,734.0000 | 72,143,466 | 2.65% | 0.00% |
| Oct. 15, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 1683 | $18.93 | 63,417.0000 | 72,143,466 | 2.73% | 0.00% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 6875 | $0.00 | 35,976.0000 | 72,143,466 | 16.04% | 0.01% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 200 | $88.90 | 61,734.0000 | 72,143,466 | 0.32% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1700 | $87.67 | 61,934.0000 | 72,143,466 | 2.67% | 0.00% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 5820 | $86.63 | 63,634.0000 | 72,143,466 | 8.38% | 0.01% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 12280 | $85.75 | 69,454.0000 | 72,143,466 | 15.02% | 0.02% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 20000 | $18.93 | 81,734.0000 | 72,143,466 | 32.40% | 0.03% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1596 | $89.22 | 61,734.0000 | 72,143,466 | 2.52% | 0.00% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 12266 | $88.73 | 63,330.0000 | 72,143,466 | 16.23% | 0.02% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 6138 | $87.90 | 75,596.0000 | 72,143,466 | 7.51% | 0.01% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 6875 | $6.89 | 68,609.0000 | 72,143,466 | 11.14% | 0.01% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 13125 | $18.93 | 81,734.0000 | 72,143,466 | 19.13% | 0.02% |
| Oct. 14, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 30,662.0000 | 72,143,466 | 39.48% | 0.03% |
| Oct. 13, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 13125 | $0.00 | 50,662.0000 | 72,143,466 | 20.58% | 0.02% |
| Oct. 1, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 970 | $86.37 | 61,734.0000 | 72,143,466 | 1.55% | 0.00% |
| Oct. 1, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 3213 | $0.00 | 63,787.0000 | 72,143,466 | 4.80% | 0.00% |
| Oct. 1, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 16787 | $0.00 | 42,851.0000 | 72,143,466 | 28.15% | 0.02% |
| Oct. 1, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 16787 | $6.89 | 78,521.0000 | 72,143,466 | 27.19% | 0.02% |
| Oct. 1, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 3213 | $18.93 | 81,734.0000 | 72,143,466 | 4.09% | 0.00% |
| Oct. 1, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 19030 | $85.43 | 62,704.0000 | 72,143,466 | 23.28% | 0.03% |
| Sept. 30, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 20000 | $6.89 | 81,734.0000 | 66,408,807 | 32.40% | 0.03% |
| Sept. 29, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 7588 | $6.89 | 69,322.0000 | 66,408,807 | 12.29% | 0.01% |
| Sept. 29, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 7588 | $85.01 | 61,734.0000 | 66,408,807 | 10.95% | 0.01% |
| Sept. 30, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 20000 | $85.06 | 61,734.0000 | 66,408,807 | 24.47% | 0.03% |
| Sept. 29, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 7588 | $0.00 | 79,638.0000 | 66,408,807 | 8.70% | 0.01% |
| Sept. 30, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 59,638.0000 | 66,408,807 | 25.11% | 0.03% |
| July 16, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 14700 | $0.00 | 67,000.0000 | 66,408,807 | 17.99% | 0.02% |
| July 15, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 874 | $84.91 | 61,788.0000 | 66,408,807 | 1.39% | 0.00% |
| July 15, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1888 | $83.87 | 62,662.0000 | 66,408,807 | 2.92% | 0.00% |
| July 15, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 54 | $85.48 | 61,734.0000 | 66,408,807 | 0.09% | 0.00% |
| July 15, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 5300 | $18.93 | 67,034.0000 | 66,408,807 | 8.59% | 0.01% |
| July 15, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 2484 | $82.67 | 64,550.0000 | 66,408,807 | 3.71% | 0.00% |
| July 16, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 14700 | $18.93 | 76,434.0000 | 66,408,807 | 23.81% | 0.02% |
| July 16, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 14700 | $85.10 | 61,734.0000 | 66,408,807 | 19.23% | 0.02% |
| July 15, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 5300 | $0.00 | 81,700.0000 | 66,408,807 | 6.09% | 0.01% |
| June 27, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 20000 | $80.02 | 61,734.0000 | 66,408,807 | 24.47% | 0.03% |
| June 27, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 20000 | $18.93 | 81,734.0000 | 66,408,807 | 32.40% | 0.03% |
| June 27, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 87,000.0000 | 66,408,807 | 18.69% | 0.03% |
| June 23, 2025 | CRESCENT BIOPHARMA, INC. | $CBIO | Balcom Alexandra | Director | A | Stock Option (Right to Buy) | 9023 | $0.00 | 9,023.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | A | Class A Common Stock | 18750 | $0.00 | 65,750.0000 | 66,408,807 | 39.89% | 0.03% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1152 | $78.28 | 64,598.0000 | 66,408,807 | 1.75% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 691 | $79.33 | 63,907.0000 | 66,408,807 | 1.07% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 2173 | $80.54 | 61,734.0000 | 66,408,807 | 3.40% | 0.00% |
| Jan. 6, 2025 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | A | Stock Option (Right to Buy) | 37500 | $0.00 | 37,500.0000 | 66,408,807 | 9999.99% | 0.06% |
| Dec. 17, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 4728 | $1.08 | 38,028.0000 | 65,678,693 | 14.20% | 0.01% |
| Dec. 17, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 8972 | $6.89 | 47,000.0000 | 65,678,693 | 23.59% | 0.01% |
| Dec. 17, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 4728 | $0.00 | 196,156.0000 | 65,678,693 | 2.35% | 0.01% |
| Dec. 17, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 8972 | $0.00 | 87,226.0000 | 65,678,693 | 9.33% | 0.01% |
| Nov. 29, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 84,200.0000 | 65,678,693 | 10.62% | 0.02% |
| Nov. 29, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 10000 | $27.85 | 43,300.0000 | 65,678,693 | 30.03% | 0.02% |
| Nov. 29, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 8142 | $95.69 | 35,158.0000 | 65,678,693 | 18.80% | 0.01% |
| Nov. 29, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1858 | $96.25 | 33,300.0000 | 65,678,693 | 5.28% | 0.00% |
| Oct. 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 94,200.0000 | 65,678,693 | 9.60% | 0.02% |
| Oct. 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 100 | $90.94 | 33,300.0000 | 65,678,693 | 0.30% | 0.00% |
| Oct. 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1600 | $90.31 | 33,400.0000 | 65,678,693 | 4.57% | 0.00% |
| Oct. 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 6320 | $89.17 | 35,000.0000 | 65,678,693 | 15.30% | 0.01% |
| Oct. 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1980 | $88.25 | 41,320.0000 | 65,678,693 | 4.57% | 0.00% |
| Oct. 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 10000 | $27.85 | 43,300.0000 | 65,678,693 | 30.03% | 0.02% |
| Sept. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 700 | $98.88 | 42,600.0000 | 58,223,339 | 1.62% | 0.00% |
| Sept. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 104,200.0000 | 58,223,339 | 8.76% | 0.02% |
| Sept. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 2963 | $101.89 | 33,300.0000 | 58,223,339 | 8.17% | 0.01% |
| Sept. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 5032 | $101.13 | 36,263.0000 | 58,223,339 | 12.19% | 0.01% |
| Sept. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1305 | $100.09 | 41,295.0000 | 58,223,339 | 3.06% | 0.00% |
| Sept. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 10000 | $27.85 | 43,300.0000 | 58,223,339 | 30.03% | 0.02% |
| Aug. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 114,200.0000 | 58,223,339 | 8.05% | 0.02% |
| Aug. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 10000 | $27.85 | 43,300.0000 | 58,223,339 | 30.03% | 0.02% |
| Aug. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 5231 | $83.87 | 38,069.0000 | 58,223,339 | 12.08% | 0.01% |
| Aug. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 4481 | $84.55 | 33,588.0000 | 58,223,339 | 11.77% | 0.01% |
| Aug. 30, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 288 | $85.96 | 33,300.0000 | 58,223,339 | 0.86% | 0.00% |
| July 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 597 | $78.05 | 41,807.0000 | 58,223,339 | 1.41% | 0.00% |
| July 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 896 | $77.02 | 42,404.0000 | 58,223,339 | 2.07% | 0.00% |
| July 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 10000 | $27.85 | 43,300.0000 | 58,223,339 | 30.03% | 0.02% |
| July 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 124,200.0000 | 58,223,339 | 7.45% | 0.02% |
| July 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1135 | $81.31 | 33,300.0000 | 58,223,339 | 3.30% | 0.00% |
| July 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1649 | $80.38 | 34,435.0000 | 58,223,339 | 4.57% | 0.00% |
| July 31, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 5723 | $79.44 | 36,084.0000 | 58,223,339 | 13.69% | 0.01% |
| June 28, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 134,200.0000 | 58,223,339 | 6.93% | 0.02% |
| June 28, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 10000 | $27.85 | 43,300.0000 | 58,223,339 | 30.03% | 0.02% |
| June 28, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 7565 | $75.15 | 35,735.0000 | 58,223,339 | 17.47% | 0.01% |
| June 28, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 1863 | $76.19 | 33,872.0000 | 58,223,339 | 5.21% | 0.00% |
| June 28, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 572 | $76.73 | 33,300.0000 | 58,223,339 | 1.69% | 0.00% |
| Jan. 5, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 58,223,339 | 9999.99% | 0.08% |
| Jan. 5, 2024 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | A | Class A Common Stock | 33300 | $0.00 | 33,300.0000 | 58,223,339 | 9999.99% | 0.06% |
| Dec. 18, 2023 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 30000 | $1.08 | 30,000.0000 | 49,668,864 | 9999.99% | 0.06% |
| Dec. 18, 2023 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 30000 | $75.82 | 0.0000 | 49,668,864 | 100.00% | 0.06% |
| Dec. 18, 2023 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 200,884.0000 | 49,668,864 | 12.99% | 0.06% |
| July 31, 2023 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Class A Common Stock | 25000 | $1.08 | 25,000.0000 | 49,668,864 | 9999.99% | 0.05% |
| July 31, 2023 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 230,884.0000 | 49,668,864 | 9.77% | 0.05% |
| July 31, 2023 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 10848 | $49.49 | 0.0000 | 49,668,864 | 100.00% | 0.02% |
| July 31, 2023 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | S | Class A Common Stock | 14152 | $48.61 | 10,848.0000 | 49,668,864 | 56.61% | 0.03% |
| Jan. 6, 2023 | Nuvalent, Inc. | $NUVL | Balcom Alexandra | Chief Financial Officer | A | Stock Option (Right to Buy) | 144200 | $0.00 | 144,200.0000 | 49,668,864 | 9999.99% | 0.29% |